TrialTargeted oncology2015
Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer.
Feby Ingriani Mardjuadi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
TrialTargeted oncology2015
Feby Ingriani Mardjuadi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.